Literature DB >> 14612502

Role of Id-2 in the maintenance of a differentiated and noninvasive phenotype in breast cancer cells.

Yoko Itahana1, Jarnail Singh, Tomoki Sumida, Jean-Philippe Coppe, Simona Parrinello, James L Bennington, Pierre-Yves Desprez.   

Abstract

Id proteins are inhibitors of basic helix-loop-helix transcription factors and generally stimulate cell proliferation and inhibit differentiation. We have shown that ectopic expression of Id-1 in murine mammary epithelial cells resulted in loss of differentiation and gain of invasive and proliferative abilities. Moreover, Id-1 was highly expressed in aggressive breast cancer cells in culture and in biopsies from infiltrating carcinomas. In contrast to Id-1, we found that, in vitro and in vivo, Id-2 mRNA and protein were up-regulated as mammary epithelial cells lost proliferative capacity and initiated differentiation. We further determined that this up-regulation of Id-2 was a necessary step toward a fully differentiated phenotype in breast cells. Here we show that one of the components of the extracellular matrix network, laminin, is responsible for the increase in Id-2 expression during differentiation. We also show that Id-2 expression is inversely correlated with the rate of proliferation in murine mammary epithelial cells and that Id-2 is expressed at a higher level in differentiated human breast cancer cells in comparison with very aggressive and metastatic cells. When reintroduced in aggressive breast cancer cells, Id-2 is able to reduce their proliferative and invasive phenotypes and decrease their level of matrix metalloproteinase 9 secretion as well as increase syndecan-1 expression. Moreover, little Id-2 protein expression is detectable in human biopsies from aggressive and invasive carcinomas in comparison with in situ carcinomas. In conclusion, Id-2 expression not only follows a pattern opposite to that of Id-1 during mammary gland development and breast cancer progression but also appears to act as an important protein for the maintenance of a differentiated and noninvasive phenotype in normal and transformed breast cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14612502

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  34 in total

1.  Loss of Id2 potentiates the tumorigenic effect of Rb inactivation in a mouse model of retinoblastoma.

Authors:  Solange Landreville; Duanduan Ma; Jun Wu; J William Harbour
Journal:  Curr Eye Res       Date:  2010-05       Impact factor: 2.424

Review 2.  Helix-loop-helix proteins in mammary gland development and breast cancer.

Authors:  Pierre-Yves Desprez; Tomoki Sumida; Jean-Philippe Coppé
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-04       Impact factor: 2.673

3.  ID4 regulates mammary gland development by suppressing p38MAPK activity.

Authors:  Jie Dong; Shixia Huang; Marian Caikovski; Shaoquan Ji; Amanda McGrath; Myra G Custorio; Chad J Creighton; Paul Maliakkal; Ekaterina Bogoslovskaia; Zhijun Du; Xiaomei Zhang; Michael T Lewis; Fred Sablitzky; Cathrin Brisken; Yi Li
Journal:  Development       Date:  2011-12       Impact factor: 6.868

4.  Aberrant expression of ID2, a suppressor of B-cell-specific gene expression, in Hodgkin's lymphoma.

Authors:  Christoph Renné; Jose Ignacio Martin-Subero; Maren Eickernjäger; Martin-Leo Hansmann; Ralf Küppers; Reiner Siebert; Andreas Bräuninger
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

5.  Parvin-beta inhibits breast cancer tumorigenicity and promotes CDK9-mediated peroxisome proliferator-activated receptor gamma 1 phosphorylation.

Authors:  Cameron N Johnstone; Perry S Mongroo; A Sophie Rich; Michael Schupp; Mark J Bowser; Andrew S Delemos; John W Tobias; Yingqiu Liu; Gregory E Hannigan; Anil K Rustgi
Journal:  Mol Cell Biol       Date:  2007-11-12       Impact factor: 4.272

6.  [Promoter methylation of ID4. A marker for recurrence-free survival in human breast cancer].

Authors:  E Noetzel; J Veeck; F Horn; A Hartmann; R Knüchel; E Dahl
Journal:  Pathologe       Date:  2008-11       Impact factor: 1.011

7.  Redefining the expression and function of the inhibitor of differentiation 1 in mammary gland development.

Authors:  Radhika Nair; Simon Junankar; Sandra O'Toole; Jaynish Shah; Alexander D Borowsky; J Michael Bishop; Alexander Swarbrick
Journal:  PLoS One       Date:  2010-08-03       Impact factor: 3.240

8.  Molecular regulation of vasculogenic mimicry in human uveal melanoma cells: role of helix-loop-helix Id2 (inhibitor of DNA binding 2).

Authors:  Fan Su; Bin Li; Jian Wang; Xiaolin Xu; Ruojin Ren; Liaoqing Li; Fei Gao; Xiaochao Liu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-11-29       Impact factor: 3.117

9.  The tetraspanin superfamily member NET-6 is a new tumor suppressor gene.

Authors:  Huayi Huang; Khalid Sossey-Alaoui; Sarah H Beachy; Joseph Geradts
Journal:  J Cancer Res Clin Oncol       Date:  2007-05-08       Impact factor: 4.553

10.  Id2 promotes the invasive growth of MCF-7 and SKOV-3 cells by a novel mechanism independent of dimerization to basic helix-loop-helix factors.

Authors:  Yuanguang Meng; Chenglei Gu; Zhiqiang Wu; Yali Zhao; Yiling Si; Xiaobing Fu; Weidong Han
Journal:  BMC Cancer       Date:  2009-03-04       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.